NEUROCRINE BIOSCIENCES Trademark

Trademark Overview


On Monday, October 15, 2018, a trademark application was filed for NEUROCRINE BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the NEUROCRINE BIOSCIENCES trademark a serial number of 88155255. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 20, 2021. This trademark is owned by Neurocrine Biosciences, Inc.. The NEUROCRINE BIOSCIENCES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy, namely, Friedreich's ataxia and congenital birth defects; Pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions, namely, rare pediatric epilepsies, SCN8A developmental and epileptic encephalopathy, and congenital adrenal hyperplasia; Pharmaceutical preparations for human use for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; Pharmaceutical preparations for human use for the treatment of endocrine diseases, disorders and conditions; Pharmaceutical preparations for human use for the treatment of hormonal diseases, disorders and conditions; Pharmaceutical preparations for human use for the treatment of genetic diseases, disorders and conditions
neurocrine biosciences

General Information


Serial Number88155255
Word MarkNEUROCRINE BIOSCIENCES
Filing DateMonday, October 15, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 20, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 24, 2020

Trademark Statements


Description of MarkThe mark consists of a triangular logo and the words "NEUROCRINE BIOSCIENCES".
Goods and ServicesPharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy, namely, Friedreich's ataxia and congenital birth defects; Pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions, namely, rare pediatric epilepsies, SCN8A developmental and epileptic encephalopathy, and congenital adrenal hyperplasia; Pharmaceutical preparations for human use for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; Pharmaceutical preparations for human use for the treatment of endocrine diseases, disorders and conditions; Pharmaceutical preparations for human use for the treatment of hormonal diseases, disorders and conditions; Pharmaceutical preparations for human use for the treatment of genetic diseases, disorders and conditions
Pseudo MarkNEURO CRINE BIO SCIENCES; NEURO ENDOCRINE BIO SCIENCES
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOSCIENCES"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 25, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Monday, December 20, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 20, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 28, 2021SOU EXTENSION 2 GRANTED
Wednesday, May 19, 2021SOU EXTENSION 2 FILED
Thursday, May 27, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 24, 2021ASSIGNED TO EXAMINER
Wednesday, May 19, 2021TEAS EXTENSION RECEIVED
Friday, October 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2020SOU EXTENSION 1 GRANTED
Wednesday, October 28, 2020SOU EXTENSION 1 FILED
Wednesday, October 28, 2020TEAS EXTENSION RECEIVED
Tuesday, May 19, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 24, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 18, 2020ASSIGNED TO LIE
Tuesday, February 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 11, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, February 11, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 11, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, February 11, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, August 15, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, August 15, 2019FINAL REFUSAL E-MAILED
Thursday, August 15, 2019FINAL REFUSAL WRITTEN
Thursday, July 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 24, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 24, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 31, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, January 31, 2019PRIORITY ACTION E-MAILED
Thursday, January 31, 2019PRIORITY ACTION WRITTEN
Thursday, January 24, 2019ASSIGNED TO EXAMINER
Friday, October 26, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 25, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 18, 2018NEW APPLICATION ENTERED IN TRAM